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The causation of acute lymphoblastic leukemia (ALL), the main subtype of childhood 
cancer, is still unresolved and the difficulty in uncovering a likely multi-factorial etiological 
pathway is compounded by biological heterogeneity of what is a relatively rare disease.1, 2
There is persuasive evidence that the major subset of ALL, B cell precursor or common 
ALL, is usually initiated pre-natally, in utero and that additional secondary genetic changes 
more proximal to diagnosis are required to trigger overt disease.2 Any putative etiologic 
mechanism has to accommodate this pattern of natural history. Among many candidate 
exposures, infection has long been regarded as a plausible causal agent for childhood ALL,3, 
4 though no specific microbial infections or transforming viruses have been identified.2, 3 
Childhood ALL does not clearly cluster geographically,3 but this is not surprising if, as 
postulated, ALL causation involves a rare response to, or outcome of, a common infection of 
low or modest pathogenicity.2–4 There are, however, examples of what appear to be 
significant time/space clusters.5, 6 Historically, the first of these (in 1957-1960) was in 
Niles, a suburb of Chicago5, the most recent (1999-2004), and striking, was in Fallon, 
Nevada.6
We record here a time/space cluster of childhood B cell precursor ALL in Milan, Italy. The 
seven cases involved had different ages (2-11 years) but were diagnosed within a tight time 
window of only four weeks (14 December 2009 – 14 January 2010); three cases being 
associated with a single school and a fourth case being resident in the same area as the 
school. This led us to suspect that there might be an identifiable trigger or promoting agent 
for ALL in this particular instance, to which all cases were exposed and which occurred very 
proximal to the diagnostic time period.
The main biological features of the patients at disease presentation are shown in 
Supplementary Table 1. All were ‘common’ B cell precursor (CD10 positive) ALL, five 
female and two male, with a median age of 7·1 (range 2.1–11.9). Cytogenetic, molecular 
genetic and genomic alterations were variable but common to those generally present in 
ALL.1
We tested remission DNA of the patients for inherited or constitutive allelic variation in 
three genes associated with increased risk of B cell precursor ALL: ARID5B, IKZF1 and 
CEBPE.7 The number of risk alleles present per case varied from one to five (out of six 
possible; average three) but does not differ from that expected (Supplementary Table 1).
Figure 1 shows the monthly distribution of cases diagnosed with childhood ALL between 
January 1999 and September 2011 in Milan; the broad-based peak, determined by two 
consecutive high frequencies observed in December 2009 (three cases) and January 2010 
(four cases), has no equivalent in the considered period of 13 years (see also Supplementary 
Tables 2 and 3).
Figure 2 shows the results of the Scan statistic for the space-time analysis of ALL cases. The 
Kulldorff’s scan method8 identified only one significant cluster encompassing six 
administrative areas in the center of Milan within the time interval from 1 December 2009 to 
31 January 2010 (p-value = 0·017) (see also Supplementary Table 4). The cluster is 
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composed of four cases, compared to 0·04 expected, corresponding to a rate ratio of 100·0 
(95%CI: 26·9-256·0) for the areas and time period identified. The cases are exactly the four 
children resident in the surroundings of the school, three of them attending the school.
Due to long lasting refurbishment, the primary school was not in operation until September 
2009; in the previous year the entire school population was temporarily hosted in the 
buildings of another school in the same city area. The concentration of all tested physical 
and chemical agents in the school as well as in the houses of cases did not deviate from 
normal ranges. Neither parents nor children had noticeable therapeutic exposures to 
postulated toxicants. None of the parents had professional exposures relevant for leukemia 
etiology. None of the cases had first level familial malignancies. (Methods and details in 
Supplementary).
There was an outbreak of pandemic AH1N1 swine flu in Milan between July and September 
2009 preceding the ALL diagnosis by around three to six months. Serological screening of 
plasma antibodies retrieved from blood smears at the time of ALL diagnosis (but before 
instigation of treatment) revealed that all seven were seropositive (titre range: 160 to 640; 
see Supplementary Table 5). In plasma samples taken in the same time period from 192 
healthy children from Milan, 62 (32.3%) were seropositive suggesting the 100% positivity 
of the seven cases was significant (p<0.001). Five cases of ALL diagnosed before the 
outbreak were, as expected, all seronegative. Of four solid pediatric tumors (Wilm’s) 
diagnosed in Milan following the outbreak, only one was seropositive.
If abnormal immune responses to the widespread pandemic of AH1N1 served as a proximal 
trigger for ALL in the seven cases, then these cases would have to be ‘susceptibles’. The 
‘delayed infection’ hypothesis2 predicts that B cell precursor ALL may be triggered by 
immune response signals but that risk is contingent upon deficits of common infections in 
infancy that are required to prime the neonatal and infant immune system. This is endorsed 
by measurement of social contacts in infancy as surrogates for common infections9–11 and 
by modelling in mice.12, 13
We therefore investigated these characteristics in the seven families involved in the cluster. 
These were compared to a small series of control cases (Supplementary Table 6). Six out of 
seven cases were first born compared with nine out of 14 for the controls. All seven cases 
had parents of medium to high socio-economic class compared with only two of the 20 
controls. None of the seven cases attended day care in the first year of life (except for just 
one week in one case). Two of the seven cases attended day care in the 2-3 years of life 
compared with 8/14 controls. Of note is the related fact that the school with three cases 
serves an inner area of Milan of high socio-economic status professional parents.
A plausible explanation for the time/space cluster in Milan is that the AH1N1 epidemic 
provided a strong immunological or inflammatory signal that triggered conversion to clinical 
ALL in a small number of individuals harboring clinically silent pre-leukemic clones but 
who also were at risk of abnormal response to AH1N1 because of a prior deficit of microbial 
exposures in infancy that prime or modulate the naïve immune system network.2
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However, the causal explanation for the cluster we propose is based on associations and we 
cannot formally exclude a role for chance alone. It is therefore tentative. We encourage other 
investigators to scrutinize incidence data, both nationally and at local levels or within school 
systems to see if other increases in incidence occurred shortly after the 2009 pandemic of 
AH1N1.
We do not suggest that AH1N1 has a unique etiological role in childhood ALL or that it 
poses a public health concern. ALL will, at most, be an extremely rare consequence of 
AH1N1 infection as part of a multi-factorial etiology. We would anticipate that other rare 
space/time clusters of childhood ALL may also be due to a promotional effect of infectious 
agents but not to AH1N1. Influenza viruses may, however, merit further study as indirect, 
promotional agents for ALL. A prior study noted an association between epidemics of 
seasonal influenza in the UK and significant increases in the incidence of ALL that follow 
very shortly (~6 months) thereafter.14 AH1N1, other influenza viruses and, possibly, other 
viral or bacterial infections may act as triggers or promoters of ALL.
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Figure 1. 
Monthly distribution of the children diagnosed with ALL between January 1999 and 
September 2011 in Milan, Italy. Mean incidence and plus/minus one standard deviation. The 
arrow indicates the time period in object.
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Figure 2. 
Representation of most likely spatial ALL clusters identified with Scan statistic in Milan, 
1999-2010, considering a monthly time interval. The only statistically significant spatial 
cluster is in red, while different shades of grey identify non-statistically significant spatial 
clusters, with specification of corresponding time interval. The site of residence of leukemia 
cases is indicated by stars (black stars represent the three cases attending the same school). 
The location of the school of cases is represented by a black dot, while the open dot 
indicates the school where cases were temporarily hosted and where controls were recruited.
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